(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of GLB1 mRNA] CTD PMID:31150632 1,1-dichloroethene increases expression ISO RGD:10651 6480464 vinylidene chloride results in increased expression of GLB1 mRNA CTD PMID:26682919 1,2-dimethylhydrazine multiple interactions ISO RGD:10651 6480464 Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in increased expression of GLB1 mRNA] CTD PMID:22206623 1,2-dimethylhydrazine increases expression ISO RGD:10651 6480464 1, 2-Dimethylhydrazine results in increased expression of GLB1 mRNA CTD PMID:22206623 17alpha-ethynylestradiol affects expression ISO RGD:10651 6480464 Ethinyl Estradiol affects the expression of GLB1 mRNA CTD PMID:17555576 17beta-estradiol decreases expression ISO RGD:1347574 6480464 Estradiol results in decreased expression of GLB1 protein CTD PMID:17075048 17beta-estradiol increases expression ISO RGD:10651 6480464 Estradiol results in increased expression of GLB1 mRNA CTD PMID:15289156 17beta-estradiol multiple interactions ISO RGD:1347574 6480464 fulvestrant inhibits the reaction [Estradiol results in decreased expression of GLB1 protein] CTD PMID:17075048 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:1347574 6480464 2 more ... CTD PMID:31675489 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:10651 6480464 Tetrachlorodibenzodioxin affects the expression of GLB1 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of GLB1 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:10651 6480464 Tetrachlorodibenzodioxin results in decreased expression of GLB1 mRNA CTD PMID:33956508 2,4,6-tribromophenol decreases expression ISO RGD:1347574 6480464 2 more ... CTD PMID:31675489 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of GLB1 mRNA CTD PMID:21346803 3,4-methylenedioxymethamphetamine increases expression ISO RGD:10651 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of GLB1 mRNA CTD PMID:20188158 4,4'-sulfonyldiphenol decreases methylation ISO RGD:10651 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of GLB1 exon CTD PMID:33297965 aldehydo-D-glucose increases expression EXP 6480464 Glucose results in increased expression of GLB1 protein CTD PMID:22561310 aldehydo-D-glucose increases expression ISO RGD:1347574 6480464 Glucose results in increased expression of GLB1 protein CTD PMID:17075048 , PMID:23494737 aldehydo-D-glucose multiple interactions ISO RGD:1347574 6480464 SIRT3 protein inhibits the reaction [Glucose results in increased expression of GLB1 protein] CTD PMID:23494737 aldehydo-D-glucose multiple interactions EXP 6480464 NAD inhibits the reaction [Glucose results in increased expression of GLB1 protein] more ... CTD PMID:22561310 all-trans-retinoic acid increases expression ISO RGD:1347574 6480464 Tretinoin results in increased expression of GLB1 mRNA CTD PMID:23724009 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO RGD:1347574 6480464 pyrazolanthrone inhibits the reaction [Arsenic Trioxide results in increased activity of GLB1 protein] more ... CTD PMID:31734849 arsenic acid increases activity ISO RGD:10651 6480464 arsenic acid results in increased activity of GLB1 protein CTD PMID:26763397 arsenous acid increases expression EXP 6480464 Arsenic Trioxide results in increased expression of GLB1 protein CTD PMID:31734849 arsenous acid multiple interactions ISO RGD:1347574 6480464 pyrazolanthrone inhibits the reaction [Arsenic Trioxide results in increased activity of GLB1 protein] more ... CTD PMID:31734849 arsenous acid increases activity ISO RGD:1347574 6480464 Arsenic Trioxide results in increased activity of GLB1 protein CTD PMID:31734849 azoxystrobin multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of GLB1 mRNA CTD PMID:33854195 baicalein multiple interactions ISO RGD:1347574 6480464 baicalein inhibits the reaction [Mitomycin results in increased activity of GLB1 protein] CTD PMID:34624459 benzo[a]pyrene decreases methylation ISO RGD:10651 6480464 Benzo(a)pyrene results in decreased methylation of GLB1 intron CTD PMID:27901495 bis(2-chloroethyl) sulfide multiple interactions ISO RGD:1347574 6480464 Mustard Gas results in increased expression of and results in increased activity of GLB1 protein CTD PMID:33491125 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Testosterone] results in increased expression of GLB1 mRNA CTD PMID:26496021 bisphenol A decreases expression ISO RGD:1347574 6480464 bisphenol A results in decreased expression of GLB1 protein CTD PMID:31675489 bisphenol A increases expression ISO RGD:1347574 6480464 bisphenol A results in increased expression of GLB1 mRNA CTD PMID:29275510 bisphenol A increases methylation ISO RGD:10651 6480464 bisphenol A results in increased methylation of GLB1 promoter CTD PMID:27312807 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of GLB1 mRNA CTD PMID:25181051 Brodifacoum decreases expression EXP 6480464 bromfenacoum results in decreased expression of GLB1 protein CTD PMID:28903499 butan-1-ol multiple interactions ISO RGD:1347574 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of GLB1 mRNA CTD PMID:29432896 butanal decreases expression ISO RGD:1347574 6480464 butyraldehyde results in decreased expression of GLB1 mRNA CTD PMID:26079696 carbon nanotube decreases expression ISO RGD:10651 6480464 Nanotubes more ... CTD PMID:25620056 carbon nanotube affects expression ISO RGD:10651 6480464 Nanotubes, Carbon affects the expression of GLB1 mRNA CTD PMID:31978390 chloroquine multiple interactions ISO RGD:1347574 6480464 [Chloroquine co-treated with flavokawain B] results in decreased expression of GLB1 protein CTD PMID:30025493 chlorpyrifos multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of GLB1 mRNA CTD PMID:33854195 choline multiple interactions ISO RGD:10651 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of GLB1 mRNA CTD PMID:20938992 chromium(6+) multiple interactions EXP 6480464 [Potassium Dichromate results in increased abundance of chromium hexavalent ion] which results in increased activity of GLB1 protein, S-allylcysteine inhibits the reaction [[Potassium Dichromate results in increased abundance of chromium hexavalent ion] which results in increased activity of GLB1 protein] CTD PMID:28988497 cis-caffeic acid multiple interactions EXP 6480464 caffeic acid inhibits the reaction [Isoproterenol affects the activity of GLB1 protein] CTD PMID:20391626 cisplatin increases expression ISO RGD:1347574 6480464 Cisplatin results in increased expression of GLB1 protein CTD PMID:33491125 clofibrate decreases expression ISO RGD:10651 6480464 Clofibrate results in decreased expression of GLB1 mRNA CTD PMID:23811191 copper atom decreases expression EXP 6480464 Copper results in decreased expression of GLB1 mRNA CTD PMID:22465980 copper(0) decreases expression EXP 6480464 Copper results in decreased expression of GLB1 mRNA CTD PMID:22465980 copper(II) sulfate decreases expression ISO RGD:1347574 6480464 Copper Sulfate results in decreased expression of GLB1 mRNA CTD PMID:19549813 coumarin increases expression EXP 6480464 coumarin results in increased expression of GLB1 mRNA CTD PMID:18480146 cyclosporin A decreases expression ISO RGD:1347574 6480464 Cyclosporine results in decreased expression of GLB1 mRNA CTD PMID:25562108 D-glucose increases expression EXP 6480464 Glucose results in increased expression of GLB1 protein CTD PMID:22561310 D-glucose increases expression ISO RGD:1347574 6480464 Glucose results in increased expression of GLB1 protein CTD PMID:17075048 , PMID:23494737 D-glucose multiple interactions ISO RGD:1347574 6480464 SIRT3 protein inhibits the reaction [Glucose results in increased expression of GLB1 protein] CTD PMID:23494737 D-glucose multiple interactions EXP 6480464 NAD inhibits the reaction [Glucose results in increased expression of GLB1 protein] more ... CTD PMID:22561310 dextran sulfate multiple interactions ISO RGD:10651 6480464 Erianin inhibits the reaction [Dextran Sulfate results in increased expression of GLB1 protein] CTD PMID:32272095 dextran sulfate increases expression ISO RGD:10651 6480464 Dextran Sulfate results in increased expression of GLB1 protein CTD PMID:32272095 diarsenic trioxide increases expression EXP 6480464 Arsenic Trioxide results in increased expression of GLB1 protein CTD PMID:31734849 diarsenic trioxide multiple interactions ISO RGD:1347574 6480464 pyrazolanthrone inhibits the reaction [Arsenic Trioxide results in increased activity of GLB1 protein] more ... CTD PMID:31734849 diarsenic trioxide increases activity ISO RGD:1347574 6480464 Arsenic Trioxide results in increased activity of GLB1 protein CTD PMID:31734849 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of GLB1 mRNA CTD PMID:21266533 diethylstilbestrol increases expression ISO RGD:10651 6480464 Diethylstilbestrol results in increased expression of GLB1 mRNA CTD PMID:15289156 doxorubicin increases expression ISO RGD:10651 6480464 Doxorubicin results in increased expression of GLB1 mRNA CTD PMID:25896364 doxorubicin decreases expression ISO RGD:1347574 6480464 Doxorubicin results in decreased expression of GLB1 mRNA CTD PMID:29803840 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of GLB1 mRNA CTD PMID:29391264 ferrostatin-1 multiple interactions EXP 6480464 ferrostatin-1 inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased activity of GLB1 protein] CTD PMID:33737050 fipronil increases expression EXP 6480464 fipronil results in increased expression of GLB1 mRNA CTD PMID:34044035 flavokawain B multiple interactions ISO RGD:1347574 6480464 [ATG5 protein affects the susceptibility to flavokawain B] which affects the expression of GLB1 protein, [Chloroquine co-treated with flavokawain B] results in decreased expression of GLB1 protein CTD PMID:30025493 flavokawain B increases expression ISO RGD:1347574 6480464 flavokawain B results in increased expression of GLB1 protein CTD PMID:30025493 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of GLB1 mRNA CTD PMID:24793618 folic acid multiple interactions ISO RGD:10651 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of GLB1 mRNA more ... CTD PMID:20938992 , PMID:22206623 fulvestrant multiple interactions ISO RGD:1347574 6480464 fulvestrant inhibits the reaction [Estradiol results in decreased expression of GLB1 protein] CTD PMID:17075048 genistein increases expression ISO RGD:10651 6480464 Genistein results in increased expression of GLB1 mRNA CTD PMID:15289156 , PMID:32186404 glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of GLB1 mRNA CTD PMID:24136188 glucose increases expression EXP 6480464 Glucose results in increased expression of GLB1 protein CTD PMID:22561310 glucose increases expression ISO RGD:1347574 6480464 Glucose results in increased expression of GLB1 protein CTD PMID:17075048 , PMID:23494737 glucose multiple interactions ISO RGD:1347574 6480464 SIRT3 protein inhibits the reaction [Glucose results in increased expression of GLB1 protein] CTD PMID:23494737 glucose multiple interactions EXP 6480464 NAD inhibits the reaction [Glucose results in increased expression of GLB1 protein] more ... CTD PMID:22561310 glyphosate multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of GLB1 mRNA CTD PMID:33854195 hydrogen peroxide affects expression ISO RGD:1347574 6480464 Hydrogen Peroxide affects the expression of GLB1 mRNA CTD PMID:20044591 hydrogen peroxide increases expression ISO RGD:1347574 6480464 Hydrogen Peroxide results in increased expression of GLB1 protein CTD PMID:30139380 , PMID:33491125 imidacloprid multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of GLB1 mRNA CTD PMID:33854195 isoprenaline multiple interactions EXP 6480464 caffeic acid inhibits the reaction [Isoproterenol affects the activity of GLB1 protein] CTD PMID:20391626 isoprenaline affects activity EXP 6480464 Isoproterenol affects the activity of GLB1 protein CTD PMID:20391626 ivermectin decreases expression ISO RGD:1347574 6480464 Ivermectin results in decreased expression of GLB1 protein CTD PMID:32959892 L-methionine multiple interactions ISO RGD:10651 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of GLB1 mRNA CTD PMID:20938992 lithium chloride increases activity ISO RGD:1347574 6480464 Lithium Chloride results in increased activity of GLB1 protein CTD PMID:34624459 melphalan increases expression ISO RGD:1347574 6480464 Melphalan results in increased expression of GLB1 protein CTD PMID:33491125 methotrexate increases expression ISO RGD:1347574 6480464 Methotrexate results in increased expression of GLB1 protein CTD PMID:21678067 microcystin-LR decreases activity ISO RGD:1347574 6480464 cyanoginosin LR results in decreased activity of GLB1 protein CTD PMID:33474710 mitomycin C multiple interactions ISO RGD:1347574 6480464 AKT1 protein affects the reaction [Mitomycin results in increased activity of GLB1 protein] more ... CTD PMID:34624459 mitomycin C increases activity ISO RGD:1347574 6480464 Mitomycin results in increased activity of GLB1 protein CTD PMID:34624459 myrtenal multiple interactions EXP 6480464 myrtenal inhibits the reaction [[Phenobarbital co-treated with Diethylnitrosamine] results in increased activity of GLB1 protein] CTD PMID:22436021 N-acetyl-L-cysteine multiple interactions ISO RGD:1347574 6480464 Acetylcysteine inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] which results in increased activity of GLB1 protein] more ... CTD PMID:20884875 , PMID:31551408 N-methyl-4-phenylpyridinium affects expression ISO RGD:1347574 6480464 1-Methyl-4-phenylpyridinium affects the expression of GLB1 mRNA CTD PMID:12710931 N-methyl-4-phenylpyridinium multiple interactions EXP 6480464 ferrostatin-1 inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased activity of GLB1 protein], pifithrin inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased activity of GLB1 protein] CTD PMID:33737050 N-methyl-4-phenylpyridinium increases activity EXP 6480464 1-Methyl-4-phenylpyridinium results in increased activity of GLB1 protein CTD PMID:33737050 N-nitrosodiethylamine multiple interactions EXP 6480464 [Phenobarbital co-treated with Diethylnitrosamine] results in increased activity of GLB1 protein, myrtenal inhibits the reaction [[Phenobarbital co-treated with Diethylnitrosamine] results in increased activity of GLB1 protein] CTD PMID:22436021 NAD zwitterion multiple interactions EXP 6480464 NAD inhibits the reaction [Glucose results in increased expression of GLB1 protein], SIRT1 protein promotes the reaction [NAD inhibits the reaction [Glucose results in increased expression of GLB1 protein]] CTD PMID:22561310 NAD(+) multiple interactions EXP 6480464 NAD inhibits the reaction [Glucose results in increased expression of GLB1 protein], SIRT1 protein promotes the reaction [NAD inhibits the reaction [Glucose results in increased expression of GLB1 protein]] CTD PMID:22561310 nickel atom decreases expression ISO RGD:1347574 6480464 Nickel results in decreased expression of GLB1 mRNA CTD PMID:23195993 nicotinamide multiple interactions EXP 6480464 Niacinamide inhibits the reaction [2-(2 more ... CTD PMID:22561310 , PMID:34382399 nicotinamide increases expression EXP 6480464 Niacinamide results in increased expression of GLB1 protein CTD PMID:22561310 nitric oxide decreases activity ISO RGD:1347574 6480464 Nitric Oxide results in decreased activity of GLB1 protein CTD PMID:17075048 NMN zwitterion multiple interactions ISO RGD:10651 6480464 [resveratrol co-treated with Nicotinamide Mononucleotide] inhibits the reaction [RETN protein results in increased activity of GLB1 protein] CTD PMID:23827175 perfluorooctane-1-sulfonic acid affects expression ISO RGD:10651 6480464 perfluorooctane sulfonic acid affects the expression of GLB1 mRNA CTD PMID:19429403 perfluorooctanoic acid affects expression ISO RGD:10651 6480464 perfluorooctanoic acid affects the expression of GLB1 mRNA CTD PMID:19429403 perifosine multiple interactions ISO RGD:1347574 6480464 perifosine inhibits the reaction [Mitomycin results in increased activity of GLB1 protein] CTD PMID:34624459 phenobarbital affects expression ISO RGD:1347574 6480464 Phenobarbital affects the expression of GLB1 mRNA CTD PMID:19159669 phenobarbital multiple interactions EXP 6480464 [Phenobarbital co-treated with Diethylnitrosamine] results in increased activity of GLB1 protein, myrtenal inhibits the reaction [[Phenobarbital co-treated with Diethylnitrosamine] results in increased activity of GLB1 protein] CTD PMID:22436021 picoxystrobin affects expression ISO RGD:1347574 6480464 picoxystrobin affects the expression of GLB1 mRNA CTD PMID:33512557 pirinixic acid decreases expression ISO RGD:10651 6480464 pirinixic acid results in decreased expression of GLB1 mRNA CTD PMID:20813756 , PMID:23811191 potassium dichromate multiple interactions EXP 6480464 [Potassium Dichromate results in increased abundance of chromium hexavalent ion] which results in increased activity of GLB1 protein, S-allylcysteine inhibits the reaction [[Potassium Dichromate results in increased abundance of chromium hexavalent ion] which results in increased activity of GLB1 protein] CTD PMID:28988497 pravastatin multiple interactions ISO RGD:1347574 6480464 Pravastatin inhibits the reaction [lopinavir-ritonavir drug combination results in increased activity of GLB1 protein], Pravastatin inhibits the reaction [Ritonavir results in increased activity of GLB1 protein] CTD PMID:20884875 pyrimidifen increases expression ISO RGD:1347574 6480464 pyrimidifen results in increased expression of GLB1 mRNA CTD PMID:33512557 resveratrol multiple interactions EXP 6480464 resveratrol inhibits the reaction [Glucose results in increased expression of GLB1 protein] more ... CTD PMID:22561310 , PMID:23104429 resveratrol multiple interactions ISO RGD:10651 6480464 [resveratrol co-treated with Nicotinamide Mononucleotide] inhibits the reaction [RETN protein results in increased activity of GLB1 protein] CTD PMID:23827175 ritonavir multiple interactions ISO RGD:1347574 6480464 Acetylcysteine inhibits the reaction [Ritonavir results in increased activity of GLB1 protein] more ... CTD PMID:20884875 ritonavir increases activity ISO RGD:1347574 6480464 Ritonavir results in increased activity of GLB1 protein CTD PMID:20884875 rotenone affects expression ISO RGD:1347574 6480464 Rotenone affects the expression of GLB1 mRNA CTD PMID:33512557 S-allylcysteine multiple interactions EXP 6480464 S-allylcysteine inhibits the reaction [[Potassium Dichromate results in increased abundance of chromium hexavalent ion] which results in increased activity of GLB1 protein] CTD PMID:28988497 SB 203580 multiple interactions ISO RGD:1347574 6480464 pyrazolanthrone promotes the reaction [SB 203580 inhibits the reaction [Arsenic Trioxide results in increased activity of GLB1 protein]] more ... CTD PMID:31734849 silicon dioxide decreases expression ISO RGD:1347574 6480464 Silicon Dioxide analog results in decreased expression of GLB1 mRNA CTD PMID:25895662 simvastatin multiple interactions ISO RGD:1347574 6480464 Simvastatin inhibits the reaction [Coal Ash results in increased expression of GLB1 protein] CTD PMID:26773838 sirolimus decreases expression EXP 6480464 Sirolimus results in decreased expression of GLB1 protein CTD PMID:22561310 sirolimus multiple interactions EXP 6480464 Niacinamide inhibits the reaction [Sirolimus inhibits the reaction [Glucose results in increased expression of GLB1 protein]] more ... CTD PMID:22561310 sodium arsenate increases activity EXP 6480464 sodium arsenate results in increased activity of GLB1 protein CTD PMID:23104429 sodium arsenite increases activity EXP 6480464 sodium arsenite results in increased activity of GLB1 protein CTD PMID:23104429 sodium arsenite increases expression ISO RGD:10651 6480464 sodium arsenite results in increased expression of GLB1 mRNA CTD PMID:25787150 sodium arsenite multiple interactions EXP 6480464 resveratrol inhibits the reaction [sodium arsenite results in increased activity of GLB1 protein] CTD PMID:23104429 sodium fluoride increases expression ISO RGD:10651 6480464 Sodium Fluoride results in increased expression of GLB1 protein CTD PMID:28918527 Soman increases expression EXP 6480464 Soman results in increased expression of GLB1 mRNA CTD PMID:19281266 streptozocin increases expression ISO RGD:10651 6480464 Streptozocin results in increased expression of GLB1 protein CTD PMID:29673160 streptozocin multiple interactions ISO RGD:10651 6480464 2-amino-6-boronohexanoic acid inhibits the reaction [Streptozocin results in increased expression of GLB1 protein], ARG1 gene mutant form inhibits the reaction [Streptozocin results in increased expression of GLB1 protein] CTD PMID:29673160 tamoxifen affects expression ISO RGD:10651 6480464 Tamoxifen affects the expression of GLB1 mRNA CTD PMID:17555576 testosterone multiple interactions EXP 6480464 [bisphenol A co-treated with Testosterone] results in increased expression of GLB1 mRNA CTD PMID:26496021 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of GLB1 mRNA CTD PMID:31150632 tetrachloromethane decreases expression ISO RGD:10651 6480464 Carbon Tetrachloride results in decreased expression of GLB1 mRNA CTD PMID:31919559 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of GLB1 mRNA] CTD PMID:31150632 thiabendazole multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of GLB1 mRNA CTD PMID:33854195 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of GLB1 mRNA CTD PMID:34492290 trans-caffeic acid multiple interactions EXP 6480464 caffeic acid inhibits the reaction [Isoproterenol affects the activity of GLB1 protein] CTD PMID:20391626 tremolite asbestos decreases expression ISO RGD:10651 6480464 tremolite results in decreased expression of GLB1 mRNA CTD PMID:29279043 valproic acid increases expression ISO RGD:10651 6480464 Valproic Acid results in increased expression of GLB1 mRNA CTD PMID:21427059 valproic acid increases expression ISO RGD:1347574 6480464 Valproic Acid results in increased expression of GLB1 mRNA CTD PMID:23179753 , PMID:27188386 wogonin increases expression ISO RGD:1347574 6480464 wogonin results in increased expression of GLB1 protein CTD PMID:32671444 Yessotoxin increases expression ISO RGD:1347574 6480464 yessotoxin analog results in increased expression of GLB1 mRNA CTD PMID:30679557
